ABA. G. Beliakova

A. G. Beliakova

*This is an algorithmically generated author record based on publicly available information.

A. G. Beliakova has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Igor D. Sapegin

    Department of Basic and Clinical Pharmacology, Medical Academy named after S.I. Georgievsky, Crimean Federal University named after V.I. Vernadsky, Lenin Avenue 5/7, Simferopol, Republic of Crimea, Russian Federation

    1 shared publication
  • Maria I. Dmitriyevskaya

    Ордена Трудового Красного Знамени Медицинский институт им. С.И. Георгиевского, Крымский федеральный университет имени В.И. Вернадского

    1 shared publication
  • N. L. Ivantsova

    S. I. Georgievsky Medical Academy of V. I. Vernadsky Crimean Federal University

    1 shared publication
  • V M Melnikova

    Department of Basic and Clinical Pharmacology, Medical Academy named after S.I. Georgievsky, Crimean Federal University named after V.I. Vernadsky, Lenin Avenue 5/7, Simferopol, Republic of Crimea, Russian Federation

    1 shared publication

Latest Publications

  • Open Access

    Cerebral vessels reactivity disorders in microgravity and its pharmacological correction with new derivatives of 1,2,4- triazole

    by V M Melnikova, I D Sapegin, A G Beliakova

    Objective: study of vascular reactivity disorders under the action of a pathological model of microgravity and study of the pharmacological effect of 1,2,4-triazole derivatives on the reactivity of the cerebral vessels of various structures of the brain when simulating circulatory disorders under the influence of a pathological model of microgravity. Methods: the anti-orthostatic position was used as a pathological model. A series of experiments was carried out with laboratory animals, which were previously implanted with platinum electrodes in various structures of the brain. Dilator reactivity of vessels to hypercapnia (CrCO2), and constrictor reactivity of blood vessels to hyperoxia (CrO2) were studied by the hydrogen clearance method. Investigated substances were injected into the marginal vein of the rabbit ear in a dose of 25 mg/kg just before the onset of the action of the experimental models. Results: new pharmacologically active substances reduce oppression of constrictor reactivity and dilator reactivity of vessels caused by head down tilting model (HDTM) in all studied structures of the brain. Conclusion: the investigated substances are interested for further study of their effects in correction of cerebral hemodynamic with decrease in gravity.


  • LEVELING INDICATORS IL-1Β COMBINATION USAGE OF CHOLECALCIFEROL AND UV RADIATION IN COPD

    by N. L. Ivantsova, A. G. Beliakova, M. I. Dmitrievskaya

    3 subgroups of patients with COPD in remission with a serum cholecalciferol content of <20 ng / ml were identified to study the effect of cholecalciferol and UV radiation on the level of IL-1β. The 1st subgroup received vitamin D3 in dose 1000 IU (2 drops) per day. Course exposure of UV radiation 2 minimum erythemal doses (2 MED) were prescribed to the patients of the 2 nd subgroup. The 3rd subgroup included complex treatment of vitamin D and UV radiation. The control for the patients of these groups was a group of patients with COPD in remission with a serum 25 (OH) D3 content < 20 ng / ml, which were not included in the vitamin D complex and the course of UV radiation. As a result of the study, it was shown that the IL-1β index in the blood serum is significantly increased in patients with COPD with a deficiency of vitamin D, who received combination of replacement therapy with vitamin D and UV radiation. The obtained research data expands the understanding of the pathogenesis of COPD against the background of vitamin D deficiency, which should be taken into account when forming therapeutic complexes.